Skip to content

CARESCAPE Monitoring Systems ME Study

CARESCAPE Monitoring Systems ME Study

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07024459
Enrollment
80
Registered
2025-06-17
Start date
2024-06-13
Completion date
2025-06-30
Last updated
2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery, Intensive Care

Brief summary

Improving the reliability and accuracy of the current parameter measurement technologies is always based on measurement data to develop a newer generation. Different parameters from different age groups will be studied under this study protocol.

Detailed description

Improving the reliability and accuracy of the current parameter measurement technologies is always based on measurement data to develop a newer generation. In this study it is essential to gain data from different age groups; children, adults, and elderly people since they are targeted population to use the devices in the future. In different age groups, there is e.g., a different physiological factures that may affect the product under development. Different parameters will be studied under this study protocol. To get real picture of these parameters investigated, it is essential to also collect data from other parameters, e.g., electrocardiogram (ECG), oxygen saturation (SpO2) and carbon dioxide (CO2, including CO2 derived respiration rate (RR)). The results of this study are intended to be used in product development purposes and as an additional data to support conformity to the general safety and performance requirements of the Medical Device Regulation within device's Clinical Evaluation process. The study described herein is being conducted to collect feedback from the parameters studied, and to collect the parameter raw data from the patients in the hospital units using the investigational devices.

Interventions

DEVICEMonitoring

Participants will be monitored with secondary monitor collecting data from parameters under evaluation

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Able to provide written informed consent or have a Legally Designated Representative (LDR) to provide written informed consent; 2. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure; AND 3. Parameter(s) in scope of the study can be collected

Exclusion criteria

1. Are known to be pregnant; 2. Are breastfeeding; 3. Are suffering from infection(s) or immunocompromised patients that require isolation. 4. Have an implantable pacemaker if investigational parameters NMT and/or respiration rate are under evaluation 5. PI or designee decision due to subject's health condition

Design outcomes

Primary

MeasureTime frameDescription
Clinical evaluation of the performance and usabilityFrom admission to discharge, maximum of 24 hoursPrimary outcome of this study is to conduct clinical evaluation of the performance and usability of the new software and hardware features introduced to the system by collecting data and surveys.

Secondary

MeasureTime frameDescription
Collection of dataFrom admission to discharge, maximum of 24 hoursThe secondary study outcome will be reached when the minimum number of subjects with good raw data quality have been collected and analyzed for product development.

Other

MeasureTime frameDescription
Collection of safety informationFrom admission to discharge, maximum of 24 hoursCollection of number and type of AEs, SAEs and device issues

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026